Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System
暂无分享,去创建一个
J. Lancaster | P. Iozzo | R. DeFronzo | A. Gastaldelli | N. Musi | G. Daniele | D. Ciociaro | C. Triplitt | E. Cersosimo | D. Tripathy | M. Molina-Carrión | P. Fox | Marjorie Molina-Carrión | Giuseppe Daniele
[1] D. Carling,et al. Glucokinase activity in the arcuate nucleus regulates glucose intake. , 2015, The Journal of clinical investigation.
[2] J. Holst,et al. Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] G. Lohmann,et al. Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity , 2013, Diabetes Care.
[4] E. Blázquez,et al. Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake , 1996, Journal of neurochemistry.
[5] P. Marsden,et al. Correction for the Effect of Rising Plasma Glucose Levels on Quantification of MRglc with FDG-PET , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Manuel Desco,et al. The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem , 2005, Journal of neurochemistry.
[7] O B Paulson,et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. , 1999, Diabetes.
[8] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[9] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] A. Kastin,et al. Entry of exendin-4 into brain is rapid but may be limited at high doses , 2003, International Journal of Obesity.
[11] W. Banks,et al. Insulin in the brain: there and back again. , 2012, Pharmacology & therapeutics.
[12] Angela R. Laird,et al. Automated regional behavioral analysis for human brain images , 2012, Front. Neuroinform..
[13] E. Ferrannini,et al. Direct effect of GLP-1 infusion on endogenous glucose production in humans , 2012, Diabetologia.
[14] P T Fox,et al. Altered hypothalamic function in response to glucose ingestion in obese humans. , 1999, Diabetes.
[15] D. Pfaff,et al. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. , 2004, Diabetes.
[16] C. Hölscher,et al. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis , 2012, BMC Neuroscience.
[17] P. Marsden,et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. , 2002, Diabetes.
[18] R. Seeley,et al. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect. , 2014, The Journal of clinical investigation.
[19] D. Drucker,et al. Pharmacology, physiology, and mechanisms of incretin hormone action. , 2013, Cell metabolism.
[20] W. Pan,et al. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier , 2002, Journal of Molecular Neuroscience.
[21] Andrea Mari,et al. Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients , 2008, Diabetes.
[22] J. Holst,et al. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? , 2010, Diabetologia.
[23] Koen Van Laere,et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[24] J. Holst,et al. Glucagon-Like Peptide-1 Inhibits Blood-Brain Glucose Transfer in Humans , 2008, Diabetes.
[25] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] Albert Gjedde,et al. High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain , 1981, Journal of neurochemistry.
[27] Klaus Wienhard,et al. Measurement of glucose consumption using [(18)F]fluorodeoxyglucose. , 2002, Methods.
[28] R. Burcelin,et al. GLP-1, the gut-brain, and brain-periphery axes. , 2011, The review of diabetic studies : RDS.
[29] S. L. la Fleur,et al. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. , 2014, The Journal of endocrinology.